Spots Global Cancer Trial Database for Proton Beam Therapy in the Treatment of Esophageal Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Proton Beam Therapy in the Treatment of Esophageal Cancer

Official Title: A Phase II Study of Proton Beam Therapy in the Treatment of Esophageal Cancer

Study ID: NCT03482791

Conditions

Esophagus Cancer

Esophageal Cancer

Cancer of the Esophagus

Interventions

Proton beam therapy

Patient-Reported Outcome Measures

Study Description

Brief Summary: The investigators plan to include both operable and inoperable patients with esophagus cancer in this prospective trial. Since both proton and photon treatments are biologically equivalent, the investigators do not expect a difference in tumor control compared to intensity modulated radiation therapy (IMRT). The investigators have a prospective experience of physician-reported toxicity and patient outcome using IMRT for patients with inoperable esophagus cancer that will serve as a comparison group. For the resectable patients receiving trimodality therapy (chemoradiation followed by surgery), the investigators will carefully track toxicity and patient outcomes prospectively. The central hypothesis is that the biologic efficacy for tumor control should be similar between protons and photons, and therefore survival measures should be similar between the two groups, but that the main difference lies in the total severe toxicities experienced by the patients undergoing therapy.

Detailed Description: